Comparing Combined Behavioral Intervention and Ericksonian Hypnotherapy for Alcohol Addiction
Launched by BEYKOZ UNIVERSITY · Apr 1, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different types of psychological treatments for people struggling with alcohol addiction. The researchers want to see if Ericksonian Hypnotherapy, which is a more personalized approach, is just as effective or even better than the standard treatment called Combined Behavioral Intervention. The goal is to help reduce alcohol consumption and improve overall mental well-being for those with Alcohol Use Disorder.
To be part of the study, participants must be between 18 and 65 years old and diagnosed with Alcohol Use Disorder. They will be randomly assigned to one of three groups: one group will receive the standard treatment, another group will try hypnotherapy, and the last group will get educational materials about alcohol. The study will last 12 weeks, and participants will also be followed up three months after treatment to see how they are doing long-term. Throughout the study, researchers will track changes in drinking habits, cravings, mental health, and motivation to change. This research could help improve treatment options for alcohol addiction in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged between 18 and 65 years
- • Meets DSM-5 diagnostic criteria for Alcohol Use Disorder (mild to severe)
- • Medically and psychiatrically stable as determined by a clinician
- • Willing and able to participate in weekly sessions over a 12-week period
- • Provides informed consent
- Exclusion Criteria:
- • Current diagnosis of a severe psychiatric disorder (e.g., psychotic disorder, bipolar I disorder)
- • Significant cognitive impairment that would interfere with treatment participation
- • Participation in another structured addiction treatment during the study period
- • Current use of psychotropic medications that may influence outcome measures (as assessed by the clinical team)
- • Unstable medical condition requiring immediate intervention
- • Pregnancy or planning to become pregnant during the study period
About Beykoz University
Beykoz University is a prominent academic institution dedicated to advancing research and innovation in various fields, including health sciences. As a clinical trial sponsor, the university leverages its robust resources and interdisciplinary expertise to facilitate high-quality clinical research aimed at improving patient outcomes and advancing medical knowledge. With a commitment to ethical standards and regulatory compliance, Beykoz University fosters collaboration among researchers, healthcare professionals, and industry partners to ensure that clinical trials are conducted efficiently and effectively, contributing valuable insights to the scientific community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
İstanbul, , Turkey
Patients applied
Trial Officials
Gökben Hızlı Sayar, Prof
Study Chair
Üsküdar University
Selami Varol Ülker, Phd
Study Director
Üsküdar University
Metin Çınaroğlu, Phd
Principal Investigator
Istanbul Nisantasi University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported